Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.19.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Cash flows from operating activities    
Net income $ 358,347 $ 329,831
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization expense 326,471 274,842
Deferred income taxes, net (29,793) 2,180
Loss on extinguishment of debt 3,988 6,346
Provision for bad debts and inventory 1,057 2,197
Gain on involuntary conversion of assets (2,810)  
Share-based compensation expense 56,650 59,835
Net foreign currency adjustments (716) (3,884)
Changes in operating assets and liabilities:    
Accounts receivable, net (15,121) (2,087)
Inventories (1,342) (11,422)
Prepaid expenses and other assets (39,376) (74,976)
Accounts payable (81,690) 3,645
Accrued expenses and other liabilities (74,470) 54,962
Advance ticket sales 558,579 612,332
Net cash provided by operating activities 1,059,774 1,253,801
Cash flows from investing activities    
Additions to property and equipment, net (413,888) (1,251,434)
Issuance of promissory note (18,553)  
Cash received on settlement of derivatives 289 64,796
Other 4,047 501
Net cash used in investing activities (428,105) (1,186,137)
Cash flows from financing activities    
Repayments of long-term debt (2,808,615) (906,897)
Proceeds from long-term debt 2,652,000 1,445,352
Proceeds from employee related plans 11,368 19,026
Net share settlement of restricted share units (20,830) (13,415)
Purchases of treasury shares (200,071) (463,505)
Early redemption premium (117) (5,154)
Deferred financing fees (9,330) (114,254)
Net cash used in financing activities (375,595) (38,847)
Net increase in cash and cash equivalents 256,074 28,817
Cash and cash equivalents at beginning of period 163,851 176,190
Cash and cash equivalents at end of period $ 419,925 $ 205,007